Cargando…
Heart Failure Management in 2023: A Pharmacotherapy- and Lifestyle-Focused Comparison of Current International Guidelines
This review examines the pharmacotherapy and lifestyle recommendations of the most recent iterations of the Canadian Cardiovascular Society (CCS) / Canadian Heart Failure Society (CHFS), the European Society of Cardiology (ESC), and the American Heart Association (AHA) / American College of Cardiolo...
Autores principales: | MacDonald, Blair J., Virani, Sean A., Zieroth, Shelley, Turgeon, Ricky |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502425/ https://www.ncbi.nlm.nih.gov/pubmed/37720183 http://dx.doi.org/10.1016/j.cjco.2023.05.008 |
Ejemplares similares
-
Incorporation of Shared Decision-Making in International Cardiovascular Guidelines, 2012-2022
por: MacDonald, Blair J., et al.
Publicado: (2023) -
Decisional Needs and Patient Treatment Preferences for Heart Failure Medications: A Scoping Review
por: MacDonald, Blair J., et al.
Publicado: (2022) -
Aiming at harmony. Comparing and contrasting International HFrEF Guidelines
por: Tomasoni, Daniela, et al.
Publicado: (2022) -
Prospective evaluation of integrated device diagnostics for heart failure management: results of the TRIAGE‐HF study
por: Virani, Sean A., et al.
Publicado: (2018) -
Optimal Usage of Sacubitril/Valsartan for the Treatment of Heart Failure: The Importance of Optimizing Heart Failure Care in Canada
por: Huitema, Ashlay A., et al.
Publicado: (2020)